University at Buffalo - The State University of New York
Skip to Content
The p38 mitogen-activated protein kinases modulate endothelial cell survival and tissue repair | SpringerLink

Inflammation Research

, Volume 61, Issue 3, pp 233–244 | Cite as

The p38 mitogen-activated protein kinases modulate endothelial cell survival and tissue repair

  • Nobuhiro Kanaji
  • Amy Nelson
  • Diane S. Allen-Gipson
  • Tadashi Sato
  • Masanori Nakanishi
  • Xingqi Wang
  • YingJi Li
  • Hesham Basma
  • Joel Michalski
  • Maha Farid
  • Stephen I. Rennard
  • Xiangde Liu
Original Research Paper


Objective and design

This study is designed to investigate the role of p38 MAPK in modulating human pulmonary artery endothelial cells (HPAECs) survival and tissue repair functions.


HPAECs (passage 8–12) were used for all experiments. Cells were treated with IL-1β (0.5 or 2 ng/ml) or p38 inhibitor (SB203580 or SB220025, 5 μM each). Cells were also transfected with 50 nM siRNAs. Cell length was measured using ImageJ software. Collagen gel contraction and wound close assay were performed to evaluate tissue repair functions.


IL-1β activated p38 MAPK and induced morphologic change of HPAECs. The p38 inhibitors further augmented IL-1β-induced cell morphologic change, prevented cell death, and augmented collagen gel contraction. Suppression of p38α, γ, or δ, but not p38β resulted in cell morphologic alteration, and suppressing any one of p38 isoforms by siRNAs increased cell survival. Suppression of p38α or δ augmented gel contraction. While p38α suppression stimulated cell migration, suppressing the rest of three isoforms inhibit cell migration. Nuclear factor p65-siRNA blocked IL-1β-induced cell morphologic change, but did not affect p38 inhibitor-induced change.


These findings suggest that p38 MAPK may negatively modulate tissue repair functions of endothelial cells via p65 independent pathway.


p38 Interleukin-1 Endothelial cells Repair Apoptosis 


  1. 1.
    Saklatvala J, Davis W, Guesdon F. Interleukin 1 (il1) and tumour necrosis factor (tnf) signal transduction. Philos Trans R Soc Lond B Biol Sci. 1996;351(1336):151–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Chaudhuri V, Zhou L, Karasek M. Inflammatory cytokines induce the transformation of human dermal microvascular endothelial cells into myofibroblasts: a potential role in skin fibrogenesis. J Cutan Pathol. 2007;34(2):146–53.PubMedCrossRefGoogle Scholar
  3. 3.
    Kanaji N, Sat T, Wang XQ, Kim M, Nakanishi M, Li YJ, Basma H, Patil A, Michalski J, Nelson AJ, Sun J, Liu X, Rennard SI Interleukin-1beta induces endothelial-mesenchymal transition via the nf-kappa b pathway. Am J Respir Crit Care Med. 2009;179:A2343.Google Scholar
  4. 4.
    Raman M, Chen W, Cobb MH. Differential regulation and properties of mapks. Oncogene. 2007;26(22):3100–12.PubMedCrossRefGoogle Scholar
  5. 5.
    Rossa C, Ehmann K, Liu M, Patil C, Kirkwood KL. Mkk3/6–p38 mapk signaling is required for il-1beta and tnf-alpha-induced rankl expression in bone marrow stromal cells. J Interferon Cytokine Res. 2006;26(10):719–29.PubMedCrossRefGoogle Scholar
  6. 6.
    Chopra P, Kanoje V, Semwal A, Ray A. Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases. Expert Opin Investig Drugs. 2008;17(10):1411–25.PubMedCrossRefGoogle Scholar
  7. 7.
    Duan W, Chan JH, McKay K, Crosby JR, Choo HH, Leung BP, Karras JG, Wong WS. Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice. Am J Respir Crit Care Med. 2005;171(6):571–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Raia V, Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Auricchio S, Cimmino M, Cavaliere M, Nardone M, Cesaro A, et al. Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis. Thorax. 2005;60(9):773–80.PubMedCrossRefGoogle Scholar
  9. 9.
    Renda T, Baraldo S, Pelaia G, Bazzan E, Turato G, Papi A, Maestrelli P, Maselli R, Vatrella A, Fabbri LM, et al. Increased activation of p38 mapk in copd. Eur Respir J. 2008;31(1):62–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Yoshida K, Kuwano K, Hagimoto N, Watanabe K, Matsuba T, Fujita M, Inoshima I, Hara N. Map kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis. J Pathol. 2002;198(3):388–96.PubMedCrossRefGoogle Scholar
  11. 11.
    Schett G, Zwerina J, Firestein G. The p38 mitogen-activated protein kinase (mapk) pathway in rheumatoid arthritis. Ann Rheum Dis. 2008;67(7):909–16.PubMedCrossRefGoogle Scholar
  12. 12.
    Sumioka T, Ikeda K, Okada Y, Yamanaka O, Kitano A, Saika S. Inhibitory effect of blocking tgf-beta/smad signal on injury-induced fibrosis of corneal endothelium. Mol Vis. 2008;14:2272–81.PubMedGoogle Scholar
  13. 13.
    Hui L, Bakiri L, Mairhorfer A, Schweifer N, Haslinger C, Kenner L, Komnenovic V, Scheuch H, Beug H, Wagner EF. P38alpha suppresses normal and cancer cell proliferation by antagonizing the jnk-c-jun pathway. Nat Genet. 2007;39(6):741–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Hale KK, Trollinger D, Rihanek M, Manthey CL. Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J Immunol. 1999;162(7):4246–52.PubMedGoogle Scholar
  15. 15.
    Korb A, Tohidast-Akrad M, Cetin E, Axmann R, Smolen J, Schett G. Differential tissue expression and activation of p38 mapk alpha, beta, gamma, and delta isoforms in rheumatoid arthritis. Arthr Rheum. 2006;54(9):2745–56.CrossRefGoogle Scholar
  16. 16.
    Peinado VI, Pizarro S, Barbera JA. Pulmonary vascular involvement in copd. Chest. 2008;134(4):808–14.PubMedCrossRefGoogle Scholar
  17. 17.
    Carmi Y, Voronov E, Dotan S, Lahat N, Rahat MA, Fogel M, Huszar M, White MR, Dinarello CA, Apte RN. The role of macrophage-derived il-1 in induction and maintenance of angiogenesis. J Immunol. 2009;183(7):4705–14.PubMedCrossRefGoogle Scholar
  18. 18.
    Madge LA, Pober JS. A phosphatidylinositol 3-kinase/akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate nfkappab in human endothelial cells. J Biol Chem. 2000;275(20):15458–65.PubMedCrossRefGoogle Scholar
  19. 19.
    Goedert M, Cuenda A, Craxton M, Jakes R, Cohen P. Activation of the novel stress-activated protein kinase sapk4 by cytokines and cellular stresses is mediated by skk3 (mkk6); comparison of its substrate specificity with that of other sap kinases. EMBO J. 1997;16(12):3563–71.PubMedCrossRefGoogle Scholar
  20. 20.
    Bakin AV, Rinehart C, Tomlinson AK, Arteaga CL. P38 mitogen-activated protein kinase is required for tgfbeta-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci. 2002;115(Pt 15):3193–206.PubMedGoogle Scholar
  21. 21.
    Bates RC, Mercurio AM. Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell. 2003;14(5):1790–800.PubMedCrossRefGoogle Scholar
  22. 22.
    Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB. Role of reactive oxygen species in tgf-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol. 2005;16(3):667–75.PubMedCrossRefGoogle Scholar
  23. 23.
    Jung YS, Jeong EM, Park EK, Kim YM, Sohn S, Lee SH, Baik EJ, Moon CH. Cadmium induces apoptotic cell death through p38 mapk in brain microvessel endothelial cells. Eur J Pharmacol. 2008;578(1):11–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Moriue T, Igarashi J, Yoneda K, Nakai K, Kosaka H, Kubota Y. Sphingosine 1-phosphate attenuates h2o2-induced apoptosis in endothelial cells. Biochem Biophys Res Commun. 2008;368(4):852–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Nemoto S, Xiang J, Huang S, Lin A. Induction of apoptosis by sb202190 through inhibition of p38beta mitogen-activated protein kinase. J Biol Chem. 1998;273(26):16415–20.PubMedCrossRefGoogle Scholar
  26. 26.
    Tourian L Jr, Zhao H, Srikant CB. P38alpha, but not p38beta, inhibits the phosphorylation and presence of c-flips in disc to potentiate fas-mediated caspase-8 activation and type i apoptotic signaling. J Cell Sci. 2004;117(Pt 26):6459–71.PubMedCrossRefGoogle Scholar
  27. 27.
    Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J, Chien KR. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem. 1998;273(4):2161–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Silva G, Cunha A, Gregoire IP, Seldon MP, Soares MP. The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha mapk isoform. J Immunol. 2006;177(3):1894–903.PubMedGoogle Scholar
  29. 29.
    Meyer-Ter-Vehn T, Gebhardt S, Sebald W, Buttmann M, Grehn F, Schlunck G, Knaus P. P38 inhibitors prevent tgf-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthalmol Vis Sci. 2006;47(4):1500–9.PubMedCrossRefGoogle Scholar
  30. 30.
    Jung JW, Hwang SY, Hwang JS, Oh ES, Park S, Han IO. Ionising radiation induces changes associated with epithelial-mesenchymal transdifferentiation and increased cell motility of a549 lung epithelial cells. Eur J Cancer. 2007;43(7):1214–24.PubMedCrossRefGoogle Scholar
  31. 31.
    Yamanaka O, Saika S, Ohnishi Y, Kim-Mitsuyama S, Kamaraju AK, Ikeda K. Inhibition of p38map kinase suppresses fibrogenic reaction in conjunctiva in mice. Mol Vis. 2007;13:1730–9.PubMedGoogle Scholar

Copyright information

© Springer Basel AG 2011

Authors and Affiliations

  • Nobuhiro Kanaji
    • 1
    • 2
  • Amy Nelson
    • 2
  • Diane S. Allen-Gipson
    • 2
  • Tadashi Sato
    • 3
  • Masanori Nakanishi
    • 4
  • Xingqi Wang
    • 2
  • YingJi Li
    • 5
  • Hesham Basma
    • 2
  • Joel Michalski
    • 2
  • Maha Farid
    • 2
  • Stephen I. Rennard
    • 2
  • Xiangde Liu
    • 2
  1. 1.Division of Endocrinology and Metabolism, Hematology, Rheumatology and Respiratory MedicineKagawa UniversityKagawaJapan
  2. 2.Pulmonary, Critical Care, Sleep and Allergy DivisionUniversity of Nebraska Medical CenterOmahaUSA
  3. 3.Department of Respiratory MedicineJuntendo University School of MedicineTokyoJapan
  4. 4.Third Department of Internal MedicineWakayama Medical University School of MedicineWakayamaJapan
  5. 5.Department of Hygiene and Public HealthNippon Medical SchoolTokyoJapan

Personalised recommendations